News at CenExel

Psychedelics in Developmental Stuttering

Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective? PERSPECTIVE article Front. Hum. Neurosci., 18 June 2024 Sec. Speech and Language Volume 18 - 2024 | https://doi.org/10.3389/fnhum.2024.1402549 Giuseppe Pasculli1,2*...

Antipsychotic Demonstrates Efficacy

Investigational Antipsychotic Demonstrates Efficacy Without Blocking Dopamine Receptor June 7, 2024 By Kenneth J. Bender, PharmD, MA Investigational agent KarXT is a first-in-class muscarinic receptor agonist demonstrating antipsychotic efficacy and safety in short-...

Moving Forward with Muscarinics

Moving Forward with Muscarinics June, 2024 By Haig Goenjian, MD, Principal Investigator, CenExel CNS Read the article on Southern California PSYCHIATRIST here: https://www.socalpsych.org/2024/06/june-2024/  

Psychometric Rater Stress and Burnout

Salt Lake City, Utah, May 29, 2024 (GLOBE NEWSWIRE) -- Poster presented today at American Society of Clinical Pharmacology (ASCP) Annual Meeting in Miami Beach, Florida, shows:   High levels of work stress and burnout in raters for psychiatric and neurological...

Effects of the selective AMPA modulator

Effects of the selective AMPA modulator NBI-1065845 on the pharmacokinetics of midazolam or ethinyl estradiol–levonorgestrel in healthy adults Swan Lin, Adrian Ionescu, Jessica Maynard-Scott, Mike Kennedy, David P. Walling, Maura Furey, Jaskaran B. Singh First...

Xanomeline-Trospium Chloride in Schizophrenia

Efficacy and Safety of Xanomeline-Trospium Chloride in Schizophrenia A Randomized Clinical Trial Inder Kaul, MD, MPH1; Sharon Sawchak, RN1; David P. Walling, PhD2; et alCarol A. Tamminga, MD3; Alan Breier, MD4; Haiyuan Zhu, PhD1; Andrew C. Miller, PhD1; Steven...